Skip to contentB
Bausch Health Companies Inc.
B
BHCBausch Health Companies Inc. Q1 2020 · 10-Q
Revenue$2.01B$2.01B−0.2% vs Q1 2019 Net Income-$152.00M-$152.00MN/M vs Q1 2019 EPS Diluted-$0.43-$0.43N/M vs Q1 2019 Operating Income$248,000,000−13.6% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bausch Health Companies Inc. · CIK 885590 · Engraved from SEC EDGAR
Free Cash Flowderived$189,000,000−48.4% Margins · derivedOperating margin12.3%−1.9 pt vs Q1 2019
Net margin-7.6%−5.2 pt vs Q1 2019
ended Mar 31, 2020 · filed May 7, 2020 · 37 d after period end